A citation-based method for searching scientific literature

Marc S Rendell. Expert Rev Endocrinol Metab 2018
Times Cited: 6







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Yoshihito Ohtake, Tsutomu Sato, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Marina Yamaguchi, Kyoko Takami,[...]. J Med Chem 2012
96
33

Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Sumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu, Eiji Kawanishi, Yuichi Koga, Toshiaki Sakamoto, Yasuo Yamamoto, Kiichiro Ueta, Hirotaka Kimata, Keiko Nakayama,[...]. J Med Chem 2010
218
33

Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects.
Zhuang Miao, Gianluca Nucci, Neeta Amin, Raman Sharma, Vincent Mascitti, Meera Tugnait, Alfin D Vaz, Ernesto Callegari, Amit S Kalgutkar. Drug Metab Dispos 2013
83
33


Discovery of a Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor (HSK0935) for the Treatment of Type 2 Diabetes.
Yao Li, Zongjun Shi, Lei Chen, Suxin Zheng, Sheng Li, Bo Xu, Zhenhong Liu, Jianyu Liu, Chongyang Deng, Fei Ye. J Med Chem 2017
15
33

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.
Binhua Lv, Baihua Xu, Yan Feng, Kun Peng, Ge Xu, Jiyan Du, Lili Zhang, Wenbin Zhang, Ting Zhang, Liangcheng Zhu,[...]. Bioorg Med Chem Lett 2009
24
33

Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors.
Vincent Mascitti, Tristan S Maurer, Ralph P Robinson, Jianwei Bian, Carine M Boustany-Kari, Thomas Brandt, Benjamin M Collman, Amit S Kalgutkar, Michelle K Klenotic, Michael T Leininger,[...]. J Med Chem 2011
73
33




Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Wei Meng, Bruce A Ellsworth, Alexandra A Nirschl, Peggy J McCann, Manorama Patel, Ravindar N Girotra, Gang Wu, Philip M Sher, Eamonn P Morrison, Scott A Biller,[...]. J Med Chem 2008
399
33

Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Nicole C Goodwin, Ross Mabon, Bryce A Harrison, Melanie K Shadoan, Zheng Y Almstead, Yiling Xie, Jason Healy, Lindsey M Buhring, Christopher M DaCosta, Jennifer Bardenhagen,[...]. J Med Chem 2009
46
33

Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects.
Nahoko Kasahara-Ito, Hiroyuki Fukase, Yoichiro Ogama, Tomohisa Saito, Yasuhiro Ohba, Sumire Shimada, Yasuki Takano, Tomoko Ichihara, Kimio Terao, Noboru Nakamichi,[...]. Drug Res (Stuttg) 2017
11
33

Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes.
Santhosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, Dipshikha Biswas, Craig Boyle, Samuel Chackalamannil, Yan Xia, Charles Jayne, Bernard Neustadt, Jinsong Hao,[...]. ACS Med Chem Lett 2018
5
20

Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome.
Stefania Carobbio, Vanessa Pellegrinelli, Antonio Vidal-Puig. Adv Exp Med Biol 2017
101
16



Continuous and Dichotomous Metabolic Syndrome Definitions in Youth Predict Adult Type 2 Diabetes and Carotid Artery Intima Media Thickness: The Cardiovascular Risk in Young Finns Study.
Costan G Magnussen, Sanith Cheriyan, Matthew A Sabin, Markus Juonala, Juha Koskinen, Russell Thomson, Michael R Skilton, Mika Kähönen, Tomi Laitinen, Leena Taittonen,[...]. J Pediatr 2016
39
16

Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
Seyed Mohammad Riahi, Soraya Moamer, Mahshid Namdari, Yaser Mokhayeri, Mohammad Amin Pourhoseingholi, Seyed Saeed Hashemi-Nazari. Int J Cardiol 2018
9
16

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
167
16

Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study.
Farahnaz Salehinia, Hengameh Abdi, Farzad Hadaegh, Sara Serahati, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah. Diabetes Res Clin Pract 2018
8
16

American College of Endocrinology position statement on the insulin resistance syndrome.
Daniel Einhorn, Gerald M Reaven, Rhoda H Cobin, Earl Ford, Om P Ganda, Yehuda Handelsman, Richard Hellman, Paul S Jellinger, David Kendall, Ronald M Krauss,[...]. Endocr Pract 2003
499
16

Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.
Siegfried Ussar, Shiho Fujisaka, C Ronald Kahn. Mol Metab 2016
90
16

Metabolic health in normal-weight and obese individuals.
Matthias B Schulze. Diabetologia 2019
72
16

Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ.
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang, Luyong Zhang. Eur J Med Chem 2018
24
16

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.
M Angelyn Bethel, Rishi A Patel, Peter Merrill, Yuliya Lokhnygina, John B Buse, Robert J Mentz, Neha J Pagidipati, Juliana C Chan, Stephanie M Gustavson, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2018
343
16




Browning of white adipose tissue: lessons from experimental models.
Thereza Cristina Lonzetti Bargut, Vanessa Souza-Mello, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. Horm Mol Biol Clin Investig 2017
86
16

Design and validation of a population-based definition of the metabolic syndrome.
Carlos A Aguilar-Salinas, Rosalba Rojas, Clicerio Gonzalez-Villalpando, Francisco J Gómez-Pérez, Roopa Mehta, Gustavo Olaiz, Juan A Rull, David R Cox. Diabetes Care 2006
5
20


Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function.
Zhengtao Liu, Cheng Zhang, Sunjae Lee, Woonghee Kim, Martina Klevstig, Azadeh M Harzandi, Natasa Sikanic, Muhammad Arif, Marcus Ståhlman, Jens Nielsen,[...]. Metab Eng 2019
23
16

Metabolic syndrome: definitions and controversies.
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. BMC Med 2011
692
16



Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery.
Sten Madsbad, Carsten Dirksen, Jens J Holst. Lancet Diabetes Endocrinol 2014
194
16

Childhood obesity: a systems medicine approach.
William L Stone, Karen Schetzina, Charles Stuart. Front Biosci (Landmark Ed) 2016
2
50

Guideline Recommendations for Obesity Management.
Donna H Ryan, Scott Kahan. Med Clin North Am 2018
71
16


A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
Gaurav Chikara, Pramod Kumar Sharma, Pradeep Dwivedi, Jaykaran Charan, Sneha Ambwani, Surjit Singh. Indian J Clin Biochem 2018
10
16


Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
Florencia Halperin, Su-Ann Ding, Donald C Simonson, Jennifer Panosian, Ann Goebel-Fabbri, Marlene Wewalka, Osama Hamdy, Martin Abrahamson, Kerri Clancy, Kathleen Foster,[...]. JAMA Surg 2014
168
16


Regulation of hepatic glucose metabolism in health and disease.
Max C Petersen, Daniel F Vatner, Gerald I Shulman. Nat Rev Endocrinol 2017
454
16

Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.
Juan de Toro-Martín, Benoit J Arsenault, Jean-Pierre Després, Marie-Claude Vohl. Nutrients 2017
160
16

Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
Tze Pin Ng, Liang Feng, Ma Shwe Zin Nyunt, Lei Feng, Qi Gao, May Li Lim, Simon L Collinson, Mei Sian Chong, Wee Shiong Lim, Tih Shih Lee,[...]. JAMA Neurol 2016
111
16

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
Renger G Tiessen, Ciara A Kennedy, Bradley T Keller, Nancy Levin, Lisette Acevedo, Bronislava Gedulin, Andre A van Vliet, Alejandro Dorenbaum, Melissa Palmer. BMC Gastroenterol 2018
25
16

Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
Matthew J Gurka, Stephanie L Filipp, Thomas A Pearson, Mark D DeBoer. J Am Heart Assoc 2018
12
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.